| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |